Brown Advisory Inc Boston Scientific Corp Transaction History

Brown Advisory Inc

$77.3 Billion
Q3 2024

A detailed history of Brown Advisory Inc transactions in Boston Scientific Corp stock. As of the latest transaction made, Brown Advisory Inc holds 17,514 shares of BSX stock, worth $1.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,514

Previous 18,339 4.5%

Holding current value

$1.57 Million

Previous $1.41 Million 3.9%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$72.96 - $84.0 $60,191 - $69,300	-825 Reduced 4.5%	17,514 $1.47 Million
Q2 2024 Aug 14, 2024	BUY	$67.33 - $77.71 $246,293 - $284,263	3,658 Added 24.92%	18,339 $1.41 Million
Q1 2024 Apr 24, 2024	BUY	$57.6 - $68.62 $123,436 - $147,052	2,143 Added 17.09%	14,681 $1.01 Million
Q4 2023 Feb 08, 2024	BUY	$48.64 - $57.81 $535 - $635	11 Added 0.09%	12,538 $724,000
Q3 2023 Oct 24, 2023	SELL	$50.19 - $54.68 $49,838 - $54,297	-993 Reduced 7.34%	12,527 $661,000
Q2 2023 Jul 31, 2023	SELL	$49.72 - $54.64 $147,469 - $162,062	-2,966 Reduced 17.99%	13,520 $731,000
Q1 2023 May 08, 2023	BUY	$45.09 - $50.03 $115,385 - $128,026	2,559 Added 18.37%	16,486 $824,000
Q4 2022 Feb 13, 2023	SELL	$39.56 - $47.22 $54,513 - $65,069	-1,378 Reduced 9.0%	13,927 $644,000
Q3 2022 Nov 14, 2022	BUY	$36.71 - $109.66 $136,671 - $408,264	3,723 Added 32.14%	15,305 $593,000
Q2 2022 Nov 14, 2022	SELL	$35.24 - $47.1 $10,254 - $13,706	-291 Reduced 2.45%	11,582 $432,000
Q2 2022 Aug 02, 2022	SELL	$35.24 - $47.1 $10,254 - $13,706	-291 Reduced 2.45%	11,582 $432,000
Q1 2022 Nov 14, 2022	BUY	$40.9 - $45.1 $11,901 - $13,124	291 Added 2.51%	11,873 $526,000
Q1 2022 May 09, 2022	BUY	$40.9 - $45.1 $38,486 - $42,439	941 Added 8.61%	11,873 $526,000
Q4 2021 Jan 27, 2022	SELL	$38.07 - $44.87 $20,900 - $24,633	-549 Reduced 4.78%	10,932 $464,000
Q3 2021 Nov 12, 2021	BUY	$41.23 - $45.88 $7,421 - $8,258	180 Added 1.59%	11,481 $498,000
Q2 2021 Jul 29, 2021	BUY	$38.58 - $44.24 $44,212 - $50,699	1,146 Added 11.29%	11,301 $483,000
Q1 2021 May 14, 2021	SELL	$35.27 - $39.67 $846 - $952	-24 Reduced 0.24%	10,155 $393,000
Q4 2020 Feb 12, 2021	SELL	$33.15 - $41.97 $430,154 - $544,602	-12,976 Reduced 56.04%	10,179 $366,000
Q3 2020 Nov 16, 2020	BUY	$34.44 - $42.23 $33,303 - $40,836	967 Added 4.36%	23,155 $885,000
Q2 2020 Aug 14, 2020	BUY	$30.19 - $39.11 $109,227 - $141,499	3,618 Added 19.48%	22,188 $779,000
Q1 2020 May 15, 2020	SELL	$25.83 - $45.71 $39,804 - $70,439	-1,541 Reduced 7.66%	18,570 $606,000
Q4 2019 Feb 14, 2020	BUY	$37.87 - $45.37 $12,875 - $15,425	340 Added 1.72%	20,111 $910,000
Q3 2019 Nov 14, 2019	SELL	$40.31 - $43.45 $8,586 - $9,254	-213 Reduced 1.07%	19,771 $804,000
Q2 2019 Aug 12, 2019	SELL	$34.91 - $42.98 $2.84 Million - $3.49 Million	-81,316 Reduced 80.27%	19,984 $858,000
Q1 2019 May 15, 2019	BUY	$32.91 - $40.75 $92,147 - $114,100	2,800 Added 2.84%	101,300 $3.89 Million
Q4 2018 Feb 13, 2019	SELL	$31.73 - $39.04 $1.96 Million - $2.42 Million	-61,909 Reduced 38.59%	98,500 $3.48 Million
Q3 2018 Nov 13, 2018	SELL	$32.83 - $38.63 $80,564 - $94,798	-2,454 Reduced 1.51%	160,409 $6.18 Million
Q2 2018 Aug 10, 2018	BUY	$26.84 - $34.32 $3.84 Million - $4.91 Million	143,193 Added 727.98%	162,863 $5.33 Million
Q1 2018 May 14, 2018	SELL	$25.2 - $28.54 $846,720 - $958,944	-33,600 Reduced 63.07%	19,670 $537,000
Q4 2017 Feb 12, 2018	SELL	$24.79 - $29.8 $178,016 - $213,993	-7,181 Reduced 11.88%	53,270 $1.32 Million
Q3 2017 Nov 13, 2017	BUY	$26.26 - $29.17 $46,506 - $51,660	1,771 Added 3.02%	60,451 $1.76 Million
Q2 2017 Aug 14, 2017	BUY	N/A	58,680	58,680 $1.63 Million

Others Institutions Holding BSX

# of Institutions

1,542

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $129B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Inc with notifications on news.

Account

Brown Advisory Inc Boston Scientific Corp Transaction History